| Bienvenido a CICESE
Publicaciones en Innovación Biomédica
Hay 180 publicaciones en Innovación Biomédica.

Año

Autores / Publicación

2003

Peyruchaud, O., Serre, C. M., NicAmhlaoibh, R., Fournier, P. G. J., & Clézardin, P. (2003). Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. Journal of Biological Chemistry, 278(46), 45826-45832. doi: 10.1074/jbc.M309024200. (ID: 17675) (E)

2003

Vilchis Landeros, M. M., Juárez Camacho, P., & Lopez Casillas, F. (2003). El papel fisiopatológico del TGF-beta en las nefropatías de diversas etiologías: los inhibidores del TGF-beta como inhibidores terapéuticos potenciales. Gaceta Médica de México, 139(2), 126-134. (ID: 18225) (E)

2003

Felix Navarro, R. M., Lin, S., Castro Ceseña, A. B., & Casco Carrete, J. (2003). Cyanide Destruction and Simultaneous Recovery of Copper with an Electrochemical Reactor. JOURNAL OF THE ELECTROCHEMICAL SOCIETY. (ID: 24318) (E)

2003

Clézardin, P., Fournier, P. G. J., Boissier, S., & Peyruchaud, O. (2003). In vitro and in vivo antitumor effects of bisphosphonates. CURRENT MEDICINAL CHEMISTRY, 10(2), 173-180. doi: 10.2174/0929867033368529. (ID: 17674) (E)

2002

Fournier, P. G. J., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombel, M., & Clézardin, P. (2002). Bisphosphonates Inhibit Angiogenesis in Vitro and Testosterone-stimulated Vascular Regrowth in the Ventral Prostate in Castrated Rats. CANCER RESEARCH, 62(22), 6538-6544. (ID: 17676) (E)

2002

Feria, I., Pichardo, I., Juárez Camacho, P., Ramirez, V., Gonzalez, M. A., Uribe, N., Garcia Torres, R., Lopez Casillas, F., Gamba, G., & Bobadilla, N. A. (2002). Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. KIDNEY INTERNATIONAL, 63, 43-52. doi: 10.1046/j.1523-1755.2003.00707.x. (ID: 18623) (E)

2001

Juárez Camacho, P., Sanchez López, R., Stock, R. P., Olvera, A., Ramos, M. A., & Alagon, A. (2001). Characterization of the Ehrab8 gene, a marker of the late stages of the secretory pathway of Entamoeba histolytica. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 116(2), 223-228. doi: 10.1016/S0166-6851(01)00311-5. (ID: 18622) (E)

2000

Juárez Camacho, P., Sanchez López, R., Ramos, M. A., Stock, R. P., & Alagon, A. (2000). Rab8 as a Molecular Model of Vesicular Trafficking to Investigate the Latter Steps of the Secretory Pathway in Entamoeba histolytica. ARCHIVES OF MEDICAL RESEARCH, 31(4), S157-S159. doi: 10.1016/S0188-4409(00)00111-9. (ID: 18620) (E)

2000

Sanchez López, R., Gutiérrez, A., Juárez Camacho, P., Olvera, A., Olvera, F., Ramos, M. A., Sanchez, R., Saralegui, A., Stock, R. P., & Alagon, A. (2000). Molecular Genetics of the Secretory Pathway in Entamoeba histolytica: An Overview. ARCHIVES OF MEDICAL RESEARCH, 31(4), S151-S152. doi: 10.1016/S0188-4409(00)00108-9. (ID: 18621) (E)

1999

Gurrola, G. B., Rosati, B., Rocchetti, M., Pimienta Rosales, G., Zaza, A., Arcangeli, A., Olivotto, M., Possani, L. D., & Wanke, E. (1999). A toxin to nervous, cardiac, and endocrine ERG K+ channels isolated from Centruroides noxius scorpion venom. FASEB JOURNAL, 13(8), 953-962. doi: 10.1096/fj.1530-6860. (ID: 17711) (E)